Cost-effectiveness of antihypertensive treatment in Malaysia
Hypertension is a prevalent chronic disease, which is strongly related to the development of cerebrovascular and cardiovascular diseases. The prevalence of hypertension in Malaysia in subjects aged 15 years and above was estimated to be 27.8%. Cost-effectiveness analysis (CEA) compares treatment opt...
Saved in:
Main Authors: | Al-Efan, Qais Muhammad Ahmad, M. Ibrahim, M. Izham, Abdul Razak, Tariq, Ayob, Azizi |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit USM
2009
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/454/1/cost-effectiveness_of_antihypertensive_treatment_in_Malaysia.pdf http://irep.iium.edu.my/454/ http://web.usm.my/mjps/vol_7-2.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
by: Lin, Donna S-H, et al.
Published: (2021) -
Cost effectiveness analyses of pharmacological treatments in heart failure
by: Abdul Rahim, Nusaibah, et al.
Published: (2022) -
Antihypertensive and antihyperlipidemic activities of thymoquinone in l-name hypertensive rats
by: Azzubaidi, Marwan Saad, et al.
Published: (2015) -
Endovascular treatment of traumatic carotid cavernous fistula with trapping technique
by: Benny, Young, et al.
Published: (2013) -
Cost-effective analysis of proton pump inhibitors in long-term management of Gastroesophageal reflux disease: a narrative review
by: Jamshed, Shazia Qasim, et al.
Published: (2020)